Status:
COMPLETED
Non-invasive Fluorescent Imaging System for Imaging Mohs Tumor
Lead Sponsor:
University of Missouri-Columbia
Conditions:
Skin Cancer
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The objective of this study is to correlate traditional histological Mohs tissue mapping of a cutaneous tumor with the ICG-mapping procedure. The use of intradermal ICG in a cutaneous tumor during MMS...
Detailed Description
The incidence of non-melanoma skin cancers, i.e. basal cell and squamous cell carcinoma (BCC and SCC), in the US is over 5.4 million. Of these, BCC represents the majority, with an incidence of over 4...
Eligibility Criteria
Inclusion
- Subjects who are scheduled to undergo Mohs surgery for a basal cell carcinoma tumor, with a minimum tumor size of 1.5 cm, will be selected for the study procedure. A total of 10 subjects are required to complete the study. We will need to consent 15 subjects to achieve a total of 10 subjects to complete the study.
- Individuals 18 years or older
- All races and ethnicity
- Smokers and non-smokers
Exclusion
- \-
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2019
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT03430934
Start Date
July 1 2018
End Date
August 1 2019
Last Update
December 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri Health Care
Columbia, Missouri, United States, 65212